{"disease":{"id":"indobufen","name":"indobufen"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03871517","title":"INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":5438,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07089862","title":"INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}